Medication use in the neonatal intensive care unit.

Published

Journal Article

OBJECTIVE: The aim of the article is to provide an update on medication use in infants admitted to the neonatal intensive care unit (NICU) in the United States and examine how use has changed over time. STUDY DESIGN: We performed a retrospective review (2005-2010) of a large prospectively collected administrative database. RESULT: Medications most commonly administered during the study period were ampicillin, gentamicin, caffeine citrate, vancomycin, beractant, furosemide, fentanyl, dopamine, midazolam, and calfactant (56-681 exposures per 1,000 infants). Those with the greatest relative increase in use included azithromycin, sildenafil, and milrinone. Medications with the greatest relative decrease in use included theophylline, metoclopramide, and doxapram. CONCLUSION: Medication use in the NICU has changed substantially over time, and only 35% of the most commonly prescribed medications are Food and Drug Administration -approved in infants.

Full Text

Duke Authors

Cited Authors

  • Hsieh, EM; Hornik, CP; Clark, RH; Laughon, MM; Benjamin, DK; Smith, PB; Best Pharmaceuticals for Children Act—Pediatric Trials Network,

Published Date

  • October 2014

Published In

Volume / Issue

  • 31 / 9

Start / End Page

  • 811 - 821

PubMed ID

  • 24347262

Pubmed Central ID

  • 24347262

Electronic International Standard Serial Number (EISSN)

  • 1098-8785

Digital Object Identifier (DOI)

  • 10.1055/s-0033-1361933

Language

  • eng

Conference Location

  • United States